Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Completed × Chlorhexidine × Clear all

Phase

Phase NA 1 Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 1 Bacterial Infections 1

Interventions

Cyclophosphamide 259 Cisplatin 248 Radiotherapy 224 Paclitaxel 216 Docetaxel 196 Fluorouracil 195 Carboplatin 194 Doxorubicin 191 Dexamethasone 148 Gemcitabine 134 Vincristine 126 Capecitabine 116 Prednisone 113 Etoposide 112 Leucovorin 110 Methotrexate 104 Bevacizumab 104 Rituximab 98 Cytarabine 96 Filgrastim 85 Trastuzumab 81 Oxaliplatin 78 pembrolizumab 68 Pemetrexed 61 Drug Therapy 61 Tamoxifen 60 Epirubicin 57 Irinotecan 53 Chemotherapy, Adjuvant 52 Granulocyte Colony-Stimulating Factor 51

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02753387 2018-12-20

ORAL-ISO

Rennes University Hospital

Phase 3 Completed

Bacterial Infections, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡